More on 'universal'versus'selected' screening for thrombophilia: the hidden costs of false-positive diagnosis

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	239-40; author reply 241
Journal	British Journal of Haematology
Volume	134
Issue number	2
DOIs	https://doi.org/10.1111/j.1365-2141.2006.06138.x
Publication status	Published - Jul 2006

Access to Document

@article{4f155306f3fa49b3b86f7f18bf5d5b78,

title = "More on 'universal'versus'selected' screening for thrombophilia: the hidden costs of false-positive diagnosis",

keywords = "Cost-Benefit Analysis, False Positive Reactions, Humans, Mass Screening/economics, Thrombophilia/diagnosis",

author = "Favaloro, {Emmanuel J}",

year = "2006",

month = jul,

doi = "10.1111/j.1365-2141.2006.06138.x",

language = "English",

volume = "134",

pages = "239--40; author reply 241",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - More on 'universal'versus'selected' screening for thrombophilia

T2 - the hidden costs of false-positive diagnosis

AU - Favaloro, Emmanuel J

PY - 2006/7

Y1 - 2006/7

KW - Cost-Benefit Analysis

KW - False Positive Reactions

KW - Humans

KW - Mass Screening/economics

KW - Thrombophilia/diagnosis

U2 - 10.1111/j.1365-2141.2006.06138.x

DO - 10.1111/j.1365-2141.2006.06138.x

M3 - Article

C2 - 16846484

VL - 134

SP - 239-40; author reply 241

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -